The development of angioedema in a patient with type 2 diabetes due to a novel dipeptidyl peptidase-IV inhibitor, anagliptin

Hidetaka Hamasaki, Hidekatsu Yanai
  • International Journal of Cardiology, October 2013, Elsevier
  • DOI: 10.1016/j.ijcard.2013.07.257
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Hidetaka Hamasaki